BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24979587)

  • 1. Anaesthesia and orphan disease: a child with neuronal ceroid lipofuscinosis.
    Richa F
    Eur J Anaesthesiol; 2015 Mar; 32(3):213-5. PubMed ID: 24979587
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
    Drack AV; Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is myopathy with rimmed vacuoles a hallmark of juvenile neuronal ceroid lipofuscinosis (CLN3)?
    Borgione E; Castello F; Lo Giudice M; Santa Paola S; Salvatore S; Berti G; Malandrini A; Bottitta M; Musumeci SA; Scuderi C
    Neurol Sci; 2016 May; 37(5):805-7. PubMed ID: 26700800
    [No Abstract]   [Full Text] [Related]  

  • 4. Next-Generation Sequencing in the Diagnosis of Juvenile Neuronal Ceroid Lipofuscinosis.
    Deacon BS; Charles JM; Cheeseman EW; Cathey SS
    Pediatr Neurol; 2016 Sep; 62():71-2. PubMed ID: 27215405
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818814
    [No Abstract]   [Full Text] [Related]  

  • 7. A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course.
    Aberg L; Lauronen L; Hämäläinen J; Mole SE; Autti T
    Pediatr Neurol; 2009 Feb; 40(2):134-7. PubMed ID: 19135632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal ceroid lipofuscinosis with severe biventricular impairment: a rare genetic disorder with associated myopathy?
    Khanji MY; Rusinova R; Shaukat M; Sekhri N
    Eur Heart J; 2018 Jan; 39(1):74. PubMed ID: 29182766
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations in multi-gene panel testing in pediatric ophthalmology.
    Turriff AE; Cukras CA; Brooks BP; Huryn LA
    J AAPOS; 2019 Jun; 23(3):163-165.e1. PubMed ID: 30769084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaesthesia and orphan disease: A 2-year-old with neuronal ceroid lipofuscinosis.
    Wang S; Pei L
    Eur J Anaesthesiol; 2020 Feb; 37(2):138-141. PubMed ID: 31913935
    [No Abstract]   [Full Text] [Related]  

  • 12. Epileptological aspects of juvenile neuronal ceroid lipofuscinosis (CLN3 disease) through the lifespan.
    Arntsen V; Strandheim J; Helland IB; Sand T; Brodtkorb E
    Epilepsy Behav; 2019 May; 94():59-64. PubMed ID: 30884409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Characteristics of the Photoparoxysmal Response in Patients With Neuronal Ceroid Lipofuscinosis Type 2: Can EEG Be a Biomarker?
    Albert DV; Yin H; De Los Reyes EC; Vidaurre J
    J Child Neurol; 2016 Nov; 31(13):1475-1482. PubMed ID: 27445018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.
    Kühl TG; Dihanich S; Wong AM; Cooper JD
    J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Ostergaard JR; Rasmussen TB; Mølgaard H
    Neurology; 2011 Apr; 76(14):1245-51. PubMed ID: 21464428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissimilar neuropsychiatric presentations of two siblings with juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Lee TS; Poon SH; Chang P
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):123.E14-5. PubMed ID: 20160229
    [No Abstract]   [Full Text] [Related]  

  • 17. Late infantile neuronal ceroid lipofuscinosis: mutations in the CLN2 gene and clinical course in Spanish patients.
    Pérez-Poyato MS; Marfa MP; Abizanda IF; Rodriguez-Revenga L; Sánchez VC; González MJ; Puñal JE; Pérez AV; González MM; Bermejo AM; Hernández EM; Rosell MJ; Gort L; Milá M
    J Child Neurol; 2013 Apr; 28(4):470-8. PubMed ID: 22832778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kufs' disease].
    Nagasato K
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):258-61. PubMed ID: 12483876
    [No Abstract]   [Full Text] [Related]  

  • 19. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.